novo nordisk ozempic - Search News

Order byBest matchMost fresh

News

Novo Nordisk to sell Ozempic

· 21h · on MSN

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

Continue reading

· 21h · on MSN

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

· 20h · on MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

48mon MSN

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

23hon MSN

Why Novo Nordisk Stock Popped Monday

Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...

2h

Canada approves Ozempic to reduce risk of diabetic kidney disease progression

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and ...

The Pharma Letter2d

MASH win for Novo Nordisk’s Wegovy

Denmark’s Novo Nordisk scored a significant regulatory win for GLP-1drug Wegovy (semaglutide), as the US Food and Drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results